Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
6 Pediatric Medicine Breakthroughs Made Possible by Federal Research Funding
Why 340B Is Essential for Children's Health
CHA Applauds HHS’ Funding Boost for Childhood Cancer Research, Urges Further Action
6 Pediatric Medicine Breakthroughs Made Possible by Federal Research Funding
Life-changing scientific innovations from children’s hospitals show how public investment changes lives.
Oct. 14, 2025
Why 340B Is Essential for Children's Health
The program makes life-saving drugs more affordable for hospitals that care for our nation’s children.
Oct. 07, 2025
CHA Applauds HHS’ Funding Boost for Childhood Cancer Research, Urges Further Action
Children's Hospital Association encourages policymakers and leaders to keep investing in better research, innovation, and patient care for children and adolescents with cancer.
Oct. 02, 2025
